Guest Commentary

February 18, 2014 2:35 PM

Researching new cures and therapies at the University of Kansas Medical Center

“Translational research deserves to be a priority for growth in our region,” writes Douglas A. Girod, the executive vice chancellor of the University of Kansas Medical Center. “It benefits our population and our economy. As the metro area considers the future of biomedical research, KU will continue to work across all borders in its efforts to improve human health.”

Related content